Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ORAL Solo: Tofacitinib Monotherapy in RA
NCT00814307Phase 3Completed
- Sponsor
- Pfizer
- Start
- Feb 2009
- Primary completion
- Jun 2010
- Modality
- Small Molecules
- Countries
- 16
01
Overview
A Phase 3 trial of tofacitinib oral solution in rheumatoid arthritis (RA), sponsored by Pfizer. Started Feb 2009; status: completed.
02
Drugs
tofacitinib oral solution
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00814307.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00814307.